Cormorant Global Healthcare Master Fund LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cormorant Global Healthcare Master Fund LP
CIK #0001618442
EDGAR Form CIK 2011 - 2026
3 [0001618442]
4 [0001618442]
SC 13D [0001618442]
SC 13G [0001618442]
Form 13D/13G Filer Form 13D/13G Subject Filed
Cormorant Global Healthcare Master Fund LP Corbus Pharmaceuticals Holdings Inc [2024-02-05]
Cormorant Global Healthcare Master Fund LP Greenlight Biosciences Holdings PBC [2023-06-08]
Cormorant Global Healthcare Master Fund LP Edgewise Therapeutics Inc [2021-05-18]
Cormorant Global Healthcare Master Fund LP Rain Therapeutics Inc [2021-05-07]
Cormorant Global Healthcare Master Fund LP Biomea Fusion Inc [2021-04-30]
Cormorant Global Healthcare Master Fund LP Omeros Corp [2017-11-07]
Cormorant Global Healthcare Master Fund LP Vitae Pharmaceuticals Inc [2016-03-17]
Cormorant Global Healthcare Master Fund LP Zynerba Pharmaceuticals Inc [2016-03-04]
Cormorant Global Healthcare Master Fund LP Proteostasis Therapeutics Inc [2016-02-26]
Cormorant Global Healthcare Master Fund LP Omeros Corp [2015-09-28]
View All
Form 3/4/5 Subject 2011 - 2026
Cormorant Global Healthcare Master Fund LP
Cormorant Asset Management LP
Chen Bihua
Bright Minds Biosciences Inc
SAV Acquisition Corp
EyePoint Inc
MoonLake Immunotherapeutics
Cormorant Private Healthcare Fund II LP
Cormorant Private Healthcare Fund III LP
Cormorant Private Healthcare Fund IV LP
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
SAV Acquisition Corp CRBP
Common Stock
2025-12-11 Sell 30,029 $11.46 344,132
EyePoint Inc EYPT
Common Stock
2025-12-04 Sell 60,000 $15.70 942,000
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-30 Sell 5,827 $6.96 40,556
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 2,800,000 $6.61 18,508,000
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 232,460 $8.40 1,952,664
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 3,390,943 $7.58 25,703,348
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
2025-09-29 Sell 70,748 $9.38 663,616
Biomea Fusion Inc BMEA
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 91,970 $0.00
OnKure Therapeutics Inc OKUR
Class A Common Stock
2025-05-15 Sell 1,813,439 $1.85 3,354,862
OnKure Therapeutics Inc OKUR
Class A Common Stock
2025-05-12 Sell 24,300 $1.99 48,357
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-16 Buy 39,743 $23.22 922,832
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-16 Buy 3,107 $25.22 78,359
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-16 Buy 7,150 $24.03 171,814
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 8,900 $7.31 65,059
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 2,600 $8.80 22,880
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 238,097 $4.53 1,078,579
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 63,173 $5.92 373,984
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 33,343 $6.42 214,062
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 2,700 $9.26 25,002
Bright Minds Biosciences Inc DRUG
Common Shares
2024-10-15 Buy 19,169 $11.72 224,661
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com